| This week's sponsor is Ajinomoto Bio-Pharma Services. | | | |
Today's Rundown Esperion shares yo-yo as NEJM papers downplay cancer death data C4 poaches new CMO after signing $900M clinical development deal with Roche Wnt-focused Surrozen bags $50M to push regenerative medicine for liver disease [Sponsored] Incorporating The Patient Voice To Improve Ulcerative Colitis Recruitment Germany joins CARB-X, commits €40M to fighting bacteria China’s HitGen in collaboration with India’s Sun Pharma to identify small molecule leads Featured Story | | | Thursday, March 14, 2019 An NEJM paper and editorial on bempedoic acid have countered concerns that safety problems will derail Esperion Therapeutics’ efforts to bring the cholesterol drug to market. The publications side with Esperion’s interpretation that the imbalance in cancer deaths is a chance finding. |
|
|
Top Stories Thursday, March 14, 2019 C4 Therapeutics has hired Adam Crystal, M.D., Ph.D., a senior director at the Novartis Institutes for BioMedical Research, to be its new chief medical officer and help carry its targeted protein degraders closer to the clinic. Thursday, March 14, 2019 Surrozen, a biotech targeting the Wnt signaling pathway, reeled in a $50 million series B round, funding that will propel its antibody programs in liver disease and build out its platform into other areas. Monday, March 11, 2019 Strengthen Your Protocol With Patient Insights. See how Covance helps sponsors reduce patient burden to increase participation and improve patient retention. Thursday, March 14, 2019 The German government has committed €40 million ($45 million) to the development of products that tackle the rise of drug-resistant bacteria. German officials put up the money as part of their decision to join U.S. and U.K. authorities in the CARB-X partnership. Thursday, March 14, 2019 Chinese biotech HitGen has inked a collaboration deal with India’s Sun Pharma Advanced Research arm to identify novel small molecule leads. Resources Sponsored by: Patheon, part of Thermo Fisher Scientific The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing. Sponsored by: Patheon, part of Thermo Fisher Scientific Download this whitepaper to learn more. Sponsored by: ON24 Which HCP Touchpoints and channels are yielding the best results in today’s digital world? Sponsored by: Blue Matter White paper outlining the key types of cell-based immunotherapies in oncology, as well as the development and commercial outlook for each. Sponsored by: AlphaSense It’s never been more challenging to stay on top of trends and innovation shaping the future of healthcare. Discover how AI can help competitive intelligence teams achieve more proactive strategies. Sponsored by: Outer Edge Technology With FDA approval imminent, start-up Life Sciences company partners with an industry focused MSP to design and manage its regulated cloud-based infrastructure to speed time to market. Presented by: Veeva Share your thoughts on the life sciences industry's progress in improving study execution. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. BioBasics: Biotech For The Non-Scientist March 28-29, 2019 | Boston, MA Drug Development Immersion April 3-4, 2019 | Philadelphia, PA 2019 BIO International Convention June 3-6, 2019 | Philadelphia, PA Calling Europe – Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register and start preparing Today! Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register and start preparing Today! | 